MYCETOMA OF THE FOOT AND HAND: ЕTIOLOGY, EPIDEMIOLOGY, PATHOGENESIS, CLINICAL PRESENTATION, DIAGNOSIS, AND EXPERIENCE OF TREATMENT
https://doi.org/10.17650/2408-9613-2015-2-2-12-16
Abstract
The paper gives the data available in the literature on the etiology, prevalence, pathogenesis, clinical manifestations, and diagnosis of fungal and actinomycotic mycetomas. It is illustrated with patients» photos and X-ray films from the authors» clinical experience. The effective current treatment regimens for mycetomas are described.
About the Authors
S. A. BurovaRussian Federation
F. L. Emiraslanov
Russian Federation
References
1. Matsumoto T. Cutanens and subcutaneus fungal infections. In: Principles and practice of clinical mycology. C. Kibbler, D. Mackenzie, F. Odds (eds.). Wiley, 1996. Pp. 119–22.
2. Sutton D.A. Forgotten friends. Focus of fungal infections. 2003. P. 9.
3. Miles S.J. Development of a rapid molecular method for the identification
4. of fungal agents causing mycetoma. Mycoses 2005;48 Suppl 2:64.
5. De Klerk N., de Vogel C., Fahal A.H. et al. Fructose-bisphosphate aldolase and pyruvate kinase, two novel immunogens in Madurella mycetomatis. Med Mycol 2012;50(2):143–51.
6. Fahal А.G., Rahman I.A., Hasan E.М. et al. The efficacy ofitraconazole in the treatment of patients with eumycetoma due to madurella mycetomatis. Trans R Soc Trop Med Hyg 2011;105(3):127–32.
7. Fahal А.H. Mycetoma (review). Khartoum Med J 2011;4(1):514–23.
8. Maiti P.K., Haldar P.K. Mycetomas in two different trauma-prone parts of body: a study of 212 cases. Ind J Med Microbiol 1998;1:19–22.
9. Shinde R.S., Hanumantha S., Мantur B.G., Parande M.V. A rare case of mycetoma due to сurvularia. J Lab Physicians 2015;7(1):55–7.
10. Бурова С.А. Мицетома. В кн.: Клинико-морфологическая диагностика и принципы лечения кожных болезней. Под ред. М.А. Пальцева и др. М., 2006. С. 478–83. [Burova S.А. Мycetoma. In: Clinical and morphologic diagnostics and principles of skin diseases’ treatment. Ed. by М.А. Paltsev et al. Мoscow, 2006. Pp. 478–83. (In Russ.)].
11. Tomsicova A. Skin manifestation of some deep mycoses. Mycoses 1999;42 Suppl 3:216.
12. Vachkov P.I. Deep mycotic and actinomycotic infections: a twenty year longitudinal study in Sofia, Bulgaria. Mycoses 2001;44 Suppl 1:77.
13. Бурова С.А., Черный Н.И. Мицетома стопы и кисти. Успехи медицинской микологии 2004;(4):213–4. [Burova S.А., Cherny N.I. Feet and hand mycetoma. Uspekhi meditsinskoy mikologii = Successes of medical mycology 2004;(4):213–4. (In Russ.)].
14. van de Sande W.W., Gorkink R., Simons G. et al. Genotyping of Madurella mycetomatis by selective amplification of restriction fragments (amplified fragment length polymorphism) and subtype-correlation with geographical origin and lesion size. J Clin Microbiol 2005;43(9):4349–56.
15. Salfelder K. Atlas of Fungal Pathology. Current Histopathology. Dordrecht–Boston– London: Kluwer Academic Publisher Group, 1990. Рр. 116–26.
16. Бурова С.А., Черный Н.И. Способ лечения мицетомы стопы. Патент РФ
17. № 2027433. 1995. [Burova S.А., Cherny N.I. Method of feet mycetoma treatment. The patent of the Russian Federation № 2027433. 1995. (In Russ.)].
18. Fuller L.C. Revisiting antiseptic use in reducing post-surgical recurrence
19. in mycetoma. Br J Dermatol 2015;172(6):1484–5.
20. Fahal A.G. Management of mycetoma. Expert Vers Dermatol 2010;5(1):87–93.
21. Bero G.N., Desbois N., Coyo C. et al. Paradoxical response preceding control
22. of Scedosporium apiospermum mycetoma with posaconazole treatment. Infect Dis 2015;47(11):834–7.
23. Afeltra J. Mycetoma, chromoblastomycosis, paracoccidiomycosis. Mycoses 2009;52 Suppl 1:7.
Review
For citations:
Burova S.A., Emiraslanov F.L. MYCETOMA OF THE FOOT AND HAND: ЕTIOLOGY, EPIDEMIOLOGY, PATHOGENESIS, CLINICAL PRESENTATION, DIAGNOSIS, AND EXPERIENCE OF TREATMENT. Wounds and wound infections. The prof. B.M. Kostyuchenok journal. 2015;2(2):12-16. (In Russ.) https://doi.org/10.17650/2408-9613-2015-2-2-12-16